Low level of HBV-DNA is the most powerful predictive factor of better response to IFN-α therapy in chronic hepatitis B

Authors :: Brygida Knysz
Andrzej Gładysz
Paweł Piszko
Dobracki W
K. Simon
M. Zalewska
A. Głowacki
A Machaj
Małgorzata Inglot
Katarzyna Rotter
Source :: Journal of Hepatology. 28:211
Publication Year :: 1998
Publisher :: Elsevier BV, 1998.

Subjects :: Hepatology
Chronic hepatitis
business.industry
Immunology
Medicine
business
Predictive factor

Full Text Access

Tools